Scientists test new shot against deadly marburg virus
NCT ID NCT06620003
Summary
This study is testing a new vaccine designed to protect against Marburg virus disease, a severe and often fatal illness. Researchers are giving the vaccine or a placebo to 200 healthy adults to see if it is safe and if it triggers a strong immune response. The study will follow participants for one year to monitor their health and measure antibody levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARBURG VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Optimal Research; LLC
Huntsville, Alabama, 35802, United States
-
Optimal Research; LLC
Melbourne, Florida, 32934, United States
-
Optimal Research; LLC
Peoria, Illinois, 61614, United States
-
Synexus Clinical Research US, Inc.
Phoenix, Arizona, 85020, United States
-
Synexus Clinical Research US, Inc.
Chicago, Illinois, 60602, United States
-
Synexus Clinical Research US, Inc.
San Antonio, Texas, 78229, United States
-
Synexus Clinical Research US; Inc.
Dallas, Texas, 75234, United States
Conditions
Explore the condition pages connected to this study.